Flow System Design and Operation

The contract calls for the design and operation of custom flow systems capable of generating laminar, transitional, and turbulent flow conditions to accurately simulate physiological blood flow within test models using non-Newtonian fluid analogs. The systems must precisely replicate the complex rheological behavior of blood under varying shear rates and flow dynamics to support biomedical research and testing. Performance is expected to meet rigorous scientific standards for flow stability, repeatability, and control across the full range of physiological flow regimes. This is a total small business set-aside subcontract under the NAICS code 333911, issued by the FDA Negotiated Contracts Branch within the Department of Health and Human Services. Proposals are due by July 31, 2026, with the work to be performed at the designated place of performance in Silver Spring, Maryland, 20993. The solicitation was posted on July 22, 2026, and is open exclusively to small business concerns as defined by the SBA, emphasizing support for small business participation in critical health and safety research initiatives.